| Mr David A Braun, MD | |
|
1505 Eastland Dr, Suite 1100, Bloomington, IL 61701-3591 | |
| (309) 663-2100 | |
| (309) 663-8322 |
| Full Name | Mr David A Braun |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1505 Eastland Dr, Bloomington, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568422806 | NPI | - | NPPES |
| IL2613 | Other | MEDICARE GROUP # | |
| P00748543 | Other | RR INDIVIDUAL # | |
| 70254 | Other | IA | WELLMARK BCBS |
| 833120 | Other | IL | MEDICARE GROUP # |
| SS# NOT ENTERED | Medicaid | IL | |
| CA2264 | Other | RR MEDICARE GROUP # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 036104222 (Illinois) | Primary |
| 207Q00000X | Family Medicine | 33372 (Iowa) | Secondary |
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.
Probiodrug AG (Probiodrug), a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases with a particular focus on Alzheimer's disease (AD), today announced its scientists and academics collaborators published seminal findings on the role of pyroglu Aβ in AD pathology in the May 2, 2012 online edition of the journal Nature (DOI: 10.1038/nature11060). The new findings add to the growing body of evidence that pyroglu Aβ plays a crucial role in the initiation of AD. In addition, the research results further elucidate the mechanism by which pyroglu Aβ triggers neuronal toxicity.
Fluidigm Corporation announced today a collaboration with BD Biosciences, a segment of BD, to co-host a public seminar series on the isolation and analysis of single cells. Entitled A Powerful Technique for Single-Cell Analysis, the public seminar series will showcase cell isolation using the BD FACSAria III Cell Sorter and analysis using the Fluidigm BioMark HD System.
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David A Braun, MD 1505 Eastland Dr, Suite 1100, Bloomington, IL 61701-3591 Ph: (309) 663-2100 | Mr David A Braun, MD 1505 Eastland Dr, Suite 1100, Bloomington, IL 61701-3591 Ph: (309) 663-2100 |
News Archive
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.
Probiodrug AG (Probiodrug), a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases with a particular focus on Alzheimer's disease (AD), today announced its scientists and academics collaborators published seminal findings on the role of pyroglu Aβ in AD pathology in the May 2, 2012 online edition of the journal Nature (DOI: 10.1038/nature11060). The new findings add to the growing body of evidence that pyroglu Aβ plays a crucial role in the initiation of AD. In addition, the research results further elucidate the mechanism by which pyroglu Aβ triggers neuronal toxicity.
Fluidigm Corporation announced today a collaboration with BD Biosciences, a segment of BD, to co-host a public seminar series on the isolation and analysis of single cells. Entitled A Powerful Technique for Single-Cell Analysis, the public seminar series will showcase cell isolation using the BD FACSAria III Cell Sorter and analysis using the Fluidigm BioMark HD System.
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
› Verified 1 days ago
Dr. Justin James Holschbach, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 308 Saint Joseph Dr, Bloomington, IL 61701 Phone: 309-663-5050 Fax: 309-662-3401 | |
Stephen Belgrave, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-664-3170 | |
Daniel Marley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-664-3170 | |
Shilpa Mehta, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1505 Eastland Dr, Bloomington, IL 61701 Phone: 309-663-2100 Fax: 309-663-8322 | |
Kenneth Wayne Birge Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2502 E Empire St, Bloomington, IL 61704 Phone: 309-300-1031 | |
Dr. Rachel Emily Immen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3024 E Empire St Ste A, Bloomington, IL 61704 Phone: 309-556-7800 | |
Chad Osborne, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-664-3170 |